Header Logo

Onychodystrophy following the use of leflunomide for seronegative rheumatoid arthritis.

Onychodystrophy following the use of leflunomide for seronegative rheumatoid arthritis. Dermatol Ther. 2020 11; 33(6):e14491.

View in: PubMed